scholarly article | Q13442814 |
P50 | author | Nicolas Chomont | Q56909197 |
Steven G Deeks | Q57425986 | ||
Gabriela Khoury | Q63682046 | ||
Rémi Fromentin | Q89423811 | ||
Peter Bacchetti | Q89655223 | ||
Wendy Hartogenesis | Q114718150 | ||
Sharon R. Lewin | Q37618308 | ||
Miranda Z. Smith | Q38359495 | ||
Frederick M. Hecht | Q45955550 | ||
P2093 | author name string | Jenny L Anderson | |
Paul U Cameron | |||
P2860 | cites work | Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production | Q24676570 |
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions | Q28146072 | ||
Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy | Q28544949 | ||
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy | Q29615992 | ||
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation | Q29619611 | ||
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection | Q29619738 | ||
Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells | Q29622847 | ||
Differential penetration of raltegravir throughout gastrointestinal tissue: implications for eradication and cure | Q33593633 | ||
In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA. | Q33724206 | ||
Rapid turnover of 2-LTR HIV-1 DNA during early stage of highly active antiretroviral therapy. | Q33936651 | ||
A comparison of methods for measuring rectal HIV levels suggests that HIV DNA resides in cells other than CD4+ T cells, including myeloid cells | Q34033414 | ||
HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir | Q34097573 | ||
Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton. | Q34165677 | ||
Th17 cells are long lived and retain a stem cell-like molecular signature | Q34241261 | ||
Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy | Q34384134 | ||
Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy | Q34588169 | ||
STAT1 in peripheral tissue differentially regulates homing of antigen-specific Th1 and Th2 cells. | Q53629028 | ||
Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy | Q73308229 | ||
Immune reconstitution in the sigmoid colon after long-term HIV therapy | Q82949871 | ||
Cross-clade ultrasensitive PCR-based assays to measure HIV persistence in large-cohort studies | Q34593784 | ||
B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers | Q35058635 | ||
Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection | Q35064033 | ||
Expansion of HIV-specific T follicular helper cells in chronic HIV infection | Q36190755 | ||
CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function | Q36368291 | ||
Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells | Q36399680 | ||
Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production | Q36547664 | ||
Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells | Q36882465 | ||
The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence | Q37187497 | ||
Preferential HIV infection of CCR6+ Th17 cells is associated with higher levels of virus receptor expression and lack of CCR5 ligands | Q37252952 | ||
Transcriptional profiling reveals molecular signatures associated with HIV permissiveness in Th1Th17 cells and identifies peroxisome proliferator-activated receptor gamma as an intrinsic negative regulator of viral replication | Q37504330 | ||
Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues | Q37587740 | ||
HIV-1 persistence in CD4+ T cells with stem cell-like properties | Q37646541 | ||
HIV 2-long terminal repeat circular DNA is stable in primary CD4+T Cells. | Q38711403 | ||
Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. | Q38984682 | ||
Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication | Q39683177 | ||
Rules of chemokine receptor association with T cell polarization in vivo | Q39947109 | ||
Polarized secretion of CXC chemokines by human intestinal epithelial cells in response to Bacteroides fragilis enterotoxin: NF-kappa B plays a major role in the regulation of IL-8 expression | Q40813378 | ||
Circulating precursor CCR7(lo)PD-1(hi) CXCR5⁺ CD4⁺ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. | Q42261388 | ||
The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. | Q43095069 | ||
Both CD31(+) and CD31⁻ naive CD4(+) T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy | Q43941310 | ||
Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. | Q45054355 | ||
Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy | Q45732447 | ||
Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro | Q46066602 | ||
Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin β7. | Q50638760 | ||
Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards. | Q51404609 | ||
Genetic Reprogramming of Primary Human T Cells Reveals Functional Plasticity in Th Cell Differentiation | Q52005548 | ||
C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. | Q52022548 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | anti-retroviral agent | Q50430310 |
P304 | page(s) | 1511-1520 | |
P577 | publication date | 2016-01-23 | |
P1433 | published in | AIDS | Q4651863 |
P1476 | title | Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy | |
P478 | volume | 30 |
Q91790635 | Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4+ recovery |
Q57811386 | CD32 Expression is not Associated to HIV-DNA content in CD4 cell subsets of individuals with Different Levels of HIV Control |
Q89787445 | CD32+CD4+ T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency |
Q36077348 | CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART. |
Q89863542 | CD4+CD38+ central memory T cells contribute to HIV persistence in HIV-infected individuals on long-term ART |
Q45325496 | Chemokines and Chemokine Receptors: Accomplices for Human Immunodeficiency Virus Infection and Latency |
Q40472266 | Chimeric peptide-mediated siRNA transduction to inhibit HIV-1 infection. |
Q60914883 | Cofilin hyperactivation in HIV infection and targeting the cofilin pathway using an anti-αβ integrin antibody |
Q40053061 | Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure. |
Q36100333 | Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset |
Q57795385 | HIV persistence in mucosal CD4+ T cells within the lungs of adults receiving long-term suppressive antiretroviral therapy |
Q37461290 | HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy |
Q40097445 | HIV-1 selectively targets gut-homing CCR6+CD4+ T cells via mTOR-dependent mechanisms. |
Q33753961 | Human Beta Defensin 2 Selectively Inhibits HIV-1 in Highly Permissive CCR6⁺CD4⁺ T Cells. |
Q91658044 | Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy |
Q40222958 | Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy |
Q37661770 | International AIDS Society global scientific strategy: towards an HIV cure 2016. |
Q92073309 | Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement |
Q49920984 | Measuring integrated HIV DNA ex vivo and in vitro provides insights about how reservoirs are formed and maintained |
Q59361053 | Peering into the HIV reservoir |
Q100378198 | Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir |
Q92903815 | Proliferative memory SAMHD1low CD4+ T cells harbour high levels of HIV-1 with compartmentalized viral populations |
Q99548970 | Retinoic Acid Improves the Recovery of Replication-Competent Virus from Latent SIV Infected Cells |
Q58104425 | Sex-Based Differences in HIV-1 Reservoir Activity and Residual Immune Activation |
Q90733079 | The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like |
Q47141013 | The Th17 Lineage: From Barrier Surfaces Homeostasis to Autoimmunity, Cancer, and HIV-1 Pathogenesis |
Q33808773 | The loss of CCR6+ and CD161+ CD4+ T-cell homeostasis contributes to disease progression in SIV-infected rhesus macaques |
Q54242626 | Total HIV DNA: a global marker of HIV persistence. |
Q92097620 | Why and where an HIV cure is needed and how it might be achieved |
Search more.